Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Voyager Therapeutics (VYGR) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Voyager Therapeutics (VYGR) over the last 6 years, with Q3 2025 value amounting to $83000.0.

  • Voyager Therapeutics' Tax Provisions rose 9302.33% to $83000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $719000.0, marking a year-over-year decrease of 2037.65%. This contributed to the annual value of $665000.0 for FY2024, which is 5276.99% down from last year.
  • According to the latest figures from Q3 2025, Voyager Therapeutics' Tax Provisions is $83000.0, which was up 9302.33% from $15000.0 recorded in Q2 2025.
  • Voyager Therapeutics' Tax Provisions' 5-year high stood at $822000.0 during Q4 2023, with a 5-year trough of -$177000.0 in Q3 2023.
  • Over the past 3 years, Voyager Therapeutics' median Tax Provisions value was $43000.0 (recorded in 2024), while the average stood at $200727.3.
  • Per our database at Business Quant, Voyager Therapeutics' Tax Provisions tumbled by 9801.14% in 2024 and then skyrocketed by 16428.57% in 2025.
  • Quarter analysis of 3 years shows Voyager Therapeutics' Tax Provisions stood at $822000.0 in 2023, then dropped by 28.95% to $584000.0 in 2024, then plummeted by 85.79% to $83000.0 in 2025.
  • Its Tax Provisions was $83000.0 in Q3 2025, compared to $15000.0 in Q2 2025 and $37000.0 in Q1 2025.